These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 34274449)
41. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression. Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426 [TBL] [Abstract][Full Text] [Related]
42. KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer. Yang K; Li Y; Lian G; Lin H; Shang C; Zeng L; Chen S; Li J; Huang C; Huang K; Chen Y Int J Cancer; 2018 Jun; 142(11):2323-2334. PubMed ID: 29315556 [TBL] [Abstract][Full Text] [Related]
43. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition. Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242 [TBL] [Abstract][Full Text] [Related]
44. The roles of Tsang YH; Mills GB Autophagy; 2020 Oct; 16(10):1923-1924. PubMed ID: 32809888 [TBL] [Abstract][Full Text] [Related]
45. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway. Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226 [No Abstract] [Full Text] [Related]
46. Metabolic phenotypes in pancreatic cancer. Yu M; Zhou Q; Zhou Y; Fu Z; Tan L; Ye X; Zeng B; Gao W; Zhou J; Liu Y; Li Z; Lin Y; Lin Q; Chen R PLoS One; 2015; 10(2):e0115153. PubMed ID: 25719198 [TBL] [Abstract][Full Text] [Related]
47. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800 [TBL] [Abstract][Full Text] [Related]
48. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells. Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA targets autophagy in pancreatic cancer cells during cancer therapy. Wang P; Zhang L; Chen Z; Meng Z Autophagy; 2013 Dec; 9(12):2171-2. PubMed ID: 24145177 [TBL] [Abstract][Full Text] [Related]
50. PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells. Ozpolat B; Akar U; Mehta K; Lopez-Berestein G Autophagy; 2007; 3(5):480-3. PubMed ID: 17507797 [TBL] [Abstract][Full Text] [Related]
51. Wang F; Xia X; Yang C; Shen J; Mai J; Kim HC; Kirui D; Kang Y; Fleming JB; Koay EJ; Mitra S; Ferrari M; Shen H Clin Cancer Res; 2018 Jul; 24(13):3176-3185. PubMed ID: 29602802 [No Abstract] [Full Text] [Related]
52. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma. Meng F; Li W; Li C; Gao Z; Guo K; Song S Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147 [TBL] [Abstract][Full Text] [Related]
53. TRAIL mediated signaling as a double-edged sword in pancreatic cancer: Analysis of brighter and darker sides of the pathway. Farooqi AA; Zahid R; Maryam A; Naureen H; Attar R; Sabitaliyevich UY; Konysbayevna KK Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):215-220. PubMed ID: 32538774 [TBL] [Abstract][Full Text] [Related]
54. Heparanase: From basic research to therapeutic applications in cancer and inflammation. Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844 [TBL] [Abstract][Full Text] [Related]
55. B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8 Zhuang H; Zhou Z; Zhang Z; Chen X; Ma Z; Huang S; Gong Y; Zhang C; Hou B Aging (Albany NY); 2020 Dec; 13(2):2310-2329. PubMed ID: 33316775 [TBL] [Abstract][Full Text] [Related]
56. Tumor microenvironment participates in metastasis of pancreatic cancer. Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755 [TBL] [Abstract][Full Text] [Related]
57. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges. Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806 [TBL] [Abstract][Full Text] [Related]
58. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Cui J; Shi M; Xie D; Wei D; Jia Z; Zheng S; Gao Y; Huang S; Xie K Clin Cancer Res; 2014 May; 20(10):2595-606. PubMed ID: 24634381 [TBL] [Abstract][Full Text] [Related]
59. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451 [TBL] [Abstract][Full Text] [Related]
60. The marine natural product Scalarin inhibits the receptor for advanced glycation end products (RAGE) and autophagy in the PANC-1 and MIA PaCa-2 pancreatic cancer cell lines. Guzmán EA; Pitts TP; Diaz MC; Wright AE Invest New Drugs; 2019 Apr; 37(2):262-270. PubMed ID: 29998364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]